Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.

5α-reductase inhibitors, like finasteride and dutasteride, effectively treat BPH, male baldness, and hirsutism, with potential for acne and prostate cancer prevention.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Finger length ratios are not linked to the number of specific gene repeats affecting testosterone sensitivity.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

SHBG binding properties are unchanged in male liver cirrhosis patients.

New treatments for hair loss show promise, especially finasteride for men and a stronger minoxidil formula.

Testosterone replacement may help post-menopausal women with androgen insufficiency, but more research is needed on its benefits and risks.

Testosterone and DHEA can benefit women's health but must be prescribed carefully due to potential risks.

NcoA4 may have roles beyond helping control gene activity, possibly affecting cell behavior and stability.

Hair follicle bulge cells don't help skin regrow after glucocorticoid damage; interfollicular epidermis cells do.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Hormonal contraceptives can help treat acne by affecting sebum production and androgen levels.

High glucocorticoids cause pancreatic malfunction and malabsorption, reversible with enzyme supplements.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Most treatments for hair loss in 1997 were not effective for most people, and maintaining hair growth was difficult.

Local skin glucocorticoid production is crucial for healthy skin, and its disruption can lead to skin diseases.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

New treatments for excessive hair growth in women include insulin modulators and enzyme inhibitors.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.